Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge to clinical trials for cardioprotection.
- Provides detailed and critical analysis of the latest research in the field from molecular basis to potential clinical relevance- Examines the effect of fingolimod/sphingosine 1-phosphate in cardioprotection, pointing to future myocardial preventative strategies
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
1. Ischemia-Reperfusion Injury 2. Myocardial Ischemia 3. Myocardial Reperfusion 4. Cardioprotection 5. Experimental models for Ischemia reperfusion Injury 6. Role of Fingolimod in Cardioprotection
Naseer Ahmed is enthusiastic clinician-scientist who accomplished his PhD (Cardiovascular Sciences) and Postdoctoral fellowship from University of Verona, Verona, Italy. He completed his MBBS degree from Riphah International University, Islamabad, Pakistan. His research interest includes Ischemia-Reperfusion injury, Atherosclerosis & thrombosis and Arrhythmias. He is active research member of Cardiovascular Research lab, Verona and Coordinator of Functional Foods/ Complementary therapies in Cardio-metabolic disorders.